Format

Send to

Choose Destination
Cancer Gene Ther. 2005 Apr;12(4):341-9.

Tumor cells as cellular vehicles to deliver gene therapies to metastatic tumors.

Author information

1
Unidad de Hematopoyesis y Terapia Génica, CIEMAT/Fundación Marcelino Botín, Madrid, Spain.

Abstract

A long-pursued goal in cancer treatment is to deliver a therapy specifically to metastases. As a result of the disseminated nature of the metastatic disease, carrying the therapeutic agent to the sites of tumor growth represents a major step for success. We hypothesized that tumor cells injected intravenously (i.v.) into an animal with metastases would respond to many of the factors driving the metastatic process, and would target metastases. Using a model of spontaneous metastases, we report here that i.v. injected tumor cells localized on metastatic lesions. Based on this fact, we used genetically transduced tumor cells for tumor targeting of anticancer agents such as a suicide gene or an oncolytic virus, with evident antitumoral effect and negligible systemic toxicity. Therefore, autologous tumor cells may be used as cellular vehicles for systemic delivery of anticancer therapies to metastatic tumors.

PMID:
15650763
DOI:
10.1038/sj.cgt.7700801
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center